Company profile FHTX
After 39 days of this quarter the interest is at 39.0. Based on that we can calculate that during remaining 52 days it will total up to 91.0. Foghorn Therapeutics expected interest is significantly lower compared to previous quarter (-42.0%) and same quarter last year (-61.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 56 | 96 71.4% QoQ | 149 55.2% QoQ | 164 10.1% QoQ |
| 2020 | 122 117.9% YoY -25.6% QoQ | 32 -66.7% YoY -73.8% QoQ | 71 -52.3% YoY 121.9% QoQ | 192 17.1% YoY 170.4% QoQ |
| 2021 | 122 0.0% YoY -36.5% QoQ | 191 496.9% YoY 56.6% QoQ | 86 21.1% YoY -55.0% QoQ | 234 21.9% YoY 172.1% QoQ |
| 2022 | 192 57.4% YoY -17.9% QoQ | 247 29.3% YoY 28.6% QoQ | 198 130.2% YoY -19.8% QoQ | 149 -36.3% YoY -24.7% QoQ |
| 2023 | 234 21.9% YoY 57.0% QoQ | 179 -27.5% YoY -23.5% QoQ | 163 -17.7% YoY -8.9% QoQ | 157 5.4% YoY -3.7% QoQ |
| 2024 | 39 -83.3% YoY -75.2% QoQ | - | - | - |
The average 5 years interest of Foghorn Therapeutics was 11.77 per week. The last year interest of Foghorn Therapeutics compared to the last 5 years has changed by 8.84%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 22.0%.
There is not enough data for Chromatin regulatory system to provide analysis
There is not enough data for Chromatin regulatory system to provide correlation calculation
There is not enough data for Chromatin regulatory system to provide analysis
There is not enough data for FHD-286 clinical trial to provide analysis
There is not enough data for FHD-286 clinical trial to provide correlation calculation
There is not enough data for FHD-286 clinical trial to provide analysis
There is not enough data for FHD-609 synovial sarcoma to provide analysis
There is not enough data for FHD-609 synovial sarcoma to provide correlation calculation
There is not enough data for FHD-609 synovial sarcoma to provide analysis
After 39 days of this quarter the interest is at 142.0. Based on that we can calculate that during remaining 52 days it will total up to 331.0. Foghorn Therapeutics IPO expected interest is significantly higher compared to previous quarter (+1125.9%) and same quarter last year (+128.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 49 | 0 -100.0% QoQ | 85 inf% QoQ | 105 23.5% QoQ |
| 2020 | 46 -6.1% YoY -56.2% QoQ | 80 inf% YoY 73.9% QoQ | 29 -65.9% YoY -63.8% QoQ | 56 -46.7% YoY 93.1% QoQ |
| 2021 | 97 110.9% YoY 73.2% QoQ | 95 18.8% YoY -2.1% QoQ | 70 141.4% YoY -26.3% QoQ | 123 119.6% YoY 75.7% QoQ |
| 2022 | 79 -18.6% YoY -35.8% QoQ | 110 15.8% YoY 39.2% QoQ | 73 4.3% YoY -33.6% QoQ | 30 -75.6% YoY -58.9% QoQ |
| 2023 | 145 83.5% YoY 383.3% QoQ | 33 -70.0% YoY -77.2% QoQ | 45 -38.4% YoY 36.4% QoQ | 27 -10.0% YoY -40.0% QoQ |
| 2024 | 142 -2.1% YoY 425.9% QoQ | - | - | - |
The average 5 years interest of Foghorn Therapeutics IPO was 5.82 per week. The last year interest of Foghorn Therapeutics IPO compared to the last 5 years has changed by 17.01%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 24.27%.
There is not enough data for Foghorn Therapeutics reviews to provide analysis
There is not enough data for Foghorn Therapeutics reviews to provide correlation calculation
There is not enough data for Foghorn Therapeutics reviews to provide analysis
There is not enough data for Foghorn Therapeutics careers to provide analysis
There is not enough data for Foghorn Therapeutics careers to provide correlation calculation
There is not enough data for Foghorn Therapeutics careers to provide analysis
After 34 days of this quarter the interest is at 250.0. Based on that we can calculate that during remaining 58 days it will total up to 676.0. Biotechnology industry expected interest is significantly higher compared to previous quarter (+97.7%) and same quarter last year (+72.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 155 |
| 2019 | 533 243.9% QoQ | 500 -6.2% QoQ | 317 -36.6% QoQ | 377 143.2% YoY 18.9% QoQ |
| 2020 | 496 -6.9% YoY 31.6% QoQ | 352 -29.6% YoY -29.0% QoQ | 418 31.9% YoY 18.8% QoQ | 343 -9.0% YoY -17.9% QoQ |
| 2021 | 443 -10.7% YoY 29.2% QoQ | 460 30.7% YoY 3.8% QoQ | 315 -24.6% YoY -31.5% QoQ | 319 -7.0% YoY 1.3% QoQ |
| 2022 | 554 25.1% YoY 73.7% QoQ | 648 40.9% YoY 17.0% QoQ | 407 29.2% YoY -37.2% QoQ | 392 22.9% YoY -3.7% QoQ |
| 2023 | 638 15.2% YoY 62.8% QoQ | 478 -26.2% YoY -25.1% QoQ | 342 -16.0% YoY -28.5% QoQ | 250 -36.2% YoY -26.9% QoQ |
The average 5 years interest of Biotechnology industry was 33.6 per week. The last year interest of Biotechnology industry compared to the last 5 years has changed by 11.1%. The interest for Biotechnology industry is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 16.88%.
After 39 days of this quarter the interest is at 181.0. Based on that we can calculate that during remaining 52 days it will total up to 422.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 154 | 248 61.0% QoQ | 395 59.3% QoQ | 366 -7.3% QoQ |
| 2020 | 313 103.2% YoY -14.5% QoQ | 423 70.6% YoY 35.1% QoQ | 337 -14.7% YoY -20.3% QoQ | 330 -9.8% YoY -2.1% QoQ |
| 2021 | 531 69.6% YoY 60.9% QoQ | 337 -20.3% YoY -36.5% QoQ | 321 -4.7% YoY -4.7% QoQ | 324 -1.8% YoY 0.9% QoQ |
| 2022 | 609 14.7% YoY 88.0% QoQ | 492 46.0% YoY -19.2% QoQ | 423 31.8% YoY -14.0% QoQ | 471 45.4% YoY 11.3% QoQ |
| 2023 | 516 -15.3% YoY 9.6% QoQ | 528 7.3% YoY 2.3% QoQ | 423 0.0% YoY -19.9% QoQ | 421 -10.6% YoY -0.5% QoQ |
| 2024 | 181 -64.9% YoY -57.0% QoQ | - | - | - |
The average 5 years interest of Oncology therapeutics was 31.2 per week. The last year interest of Oncology therapeutics compared to the last 5 years has changed by 12.92%. The interest for Oncology therapeutics is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 42.23%.
After 39 days of this quarter the interest is at 111.0. Based on that we can calculate that during remaining 52 days it will total up to 259.0. Foghorn Therapeutics -stock -company expected interest is significantly higher compared to previous quarter (+236.4%) and same quarter last year (+451.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 42 | 88 109.5% QoQ | 30 -65.9% QoQ | 65 116.7% QoQ |
| 2020 | 50 19.0% YoY -23.1% QoQ | 19 -78.4% YoY -62.0% QoQ | 35 16.7% YoY 84.2% QoQ | 53 -18.5% YoY 51.4% QoQ |
| 2021 | 55 10.0% YoY 3.8% QoQ | 31 63.2% YoY -43.6% QoQ | 29 -17.1% YoY -6.5% QoQ | 56 5.7% YoY 93.1% QoQ |
| 2022 | 57 3.6% YoY 1.8% QoQ | 91 193.5% YoY 59.6% QoQ | 57 96.6% YoY -37.4% QoQ | 42 -25.0% YoY -26.3% QoQ |
| 2023 | 47 -17.5% YoY 11.9% QoQ | 77 -15.4% YoY 63.8% QoQ | 64 12.3% YoY -16.9% QoQ | 77 83.3% YoY 20.3% QoQ |
| 2024 | 111 136.2% YoY 44.2% QoQ | - | - | - |
The average 5 years interest of Foghorn Therapeutics -stock -company was 4.51 per week. The last year interest of Foghorn Therapeutics -stock -company compared to the last 5 years has changed by 46.78%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 43.91%.